RCB
Dead / Abandoned — Abandoned — no statement of use filed (as of 25 Sept 2023)
What this means for you
This application is over — abandoned 25 Sept 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97205537
- Mark type
- Stylized text
- Filed
- 06 Jan 2022
- Published for opposition
- 28 Jun 2022
- Abandoned
- 25 Sept 2023
- Attorney of record
- Naira Simmons
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Anti-cancer preparations; Protein arrays for diagnosing cancer; Biological preparations for the assessment of recurrence of cancer; Pharmaceutical products for the assessment of a treatment of viral and infectious diseases, for the assessment of treatment of cancer; assessment for anti-cancer preparations; assessment of protein arrays for diagnosing cancer
- Class 010 — Medical apparatus: Medical apparatus or device for assessing the recurrence of cancer; Medical diagnostic apparatus for assessing and predicting recurrence of cancer cells incorporating recorded operating system software; Medical nanites for assessing and predicting the recurrence of cancer; Medical nanorobots for assessing and predicting recurrence of cancer; Medical microrobots for assessing and predicting recurrence of cancer after treatment
- Class 042 — Scientific and technological services: Medical and scientific research in the field of assessing and predicting recurrence cancer after treatment and diagnosis; Medical research services in the field of assessing and predicting recurrence of cancer; Providing laboratory research services in the field of assessing and predicting effectiveness of treatment and diagnosis in gene expression, namely, cancer biology; Research and development of pharmaceuticals for the assessment and prediction of effectiveness of treatment of age-related diseases and cancer; Assessment and predictions of medical diagnosis and treatment of cancer; Providing information about medical research, predictions and assessments in the field of cancer
- Class 044 — Medical, beauty and agricultural services: Medical testing, prediction and assessment for diagnostic, prognosis and treatment purposes in the field of cancer research and disease classification; Providing medical, assessment and prediction information to medical professionals in the field of cancer and disease classification; Providing medical information, assessment and prediction to medical professionals on sensitivities of cancers to hormones and/or hormone therapies
- Class 045 — Legal and security services: Providing a website via a global computer network featuring supportive personal stories on the subjects of health, cancer, cancer recovery and survival
Owner
- Delphi Diagnostics, Inc., Houston, TX, US
- Delphi Diagnostics, Inc., Houston, TX, US
Prosecution history
- 25 Sept 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 25 Sept 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Jan 2023 — SOU EXTENSION 1 GRANTED
- 31 Jan 2023 — SOU EXTENSION 1 FILED
- 31 Jan 2023 — SOU TEAS EXTENSION RECEIVED
- 30 Jan 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jan 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jan 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Aug 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Jun 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jun 2022 — PUBLISHED FOR OPPOSITION
- 08 Jun 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 May 2022 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 20 May 2022 — ASSIGNED TO LIE